Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.730
+0.580 (50.45%)
At close: Oct 9, 2026, 4:00 PM EDT
1.760
+0.030 (1.73%)
After-hours: Oct 9, 2026, 7:27 PM EDT
ZYBT Revenue
In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%. That makes Zhengye Biotechnology Holding the 34,813th largest company in the world by revenue and 4,592nd in the United States.
Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
6.84
Revenue / Employee
432,572 CNY
Employees
269
Market Cap
81.51M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.36M | -69.99M | -37.56% |
| Dec 31, 2024 | 186.36M | -25.30M | -11.95% |
| Dec 31, 2023 | 211.65M | -48.62M | -18.68% |
| Dec 31, 2022 | 260.27M | 46.20M | 21.58% |
| Dec 31, 2021 | 214.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 69.39M |
| Aytu BioPharma | 57.57M |
| Cumberland Pharmaceuticals | 44.30M |
| SCYNEXIS | 19.22M |
| China Pharma Holdings | 3.91M |
| TherapeuticsMD | 3.27M |
| Optimi Health | 123.70K |
ZYBT News
- 2 months ago - Zhengye Biotechnology regains compliance with Nasdaq - TheFly
- 2 months ago - Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - GlobeNewsWire
- 2 months ago - Zhengye Biotechnology Holding Ltd trading resumes - TheFly
- 2 months ago - Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause - TheFly
- 2 months ago - Zhengye Biotechnology issues statement in response to unusual trading activity - TheFly
- 2 months ago - Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity - GlobeNewsWire
- 4 months ago - Zhengye Biotechnology receives deficiency notice over minimum bid price - TheFly
- 4 months ago - Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire